메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Scan, Play, Discover: Orca Scan Launches QR-Powered Retro Game

CAMBRIDGE, England, Sept. 3, 2025 -- 'OrcaCam' showcases Cambridge's history of innovation and demonstrates how a simple QR code can instantly launch a cross-platform game on any device - with no download required. As part of the award-winning Grand Discoveries Exhibition, Orca Scan has launched OrcaCam - a retro-style arcade game that challenges players to guide an orca through the River Cam, dodging a series of history-making innovations, including the discovery of DNA, the world's first successful heart transplant, the invention of the webcam and even the rules of football.
- 김장윤(JASON KIM) 기자
- 2025-09-03 05:00
Midea to become new FC Barcelona Main Partner

[ 메디채널 황정호 기자 ] World's No. 1 smart home appliance brand signs 5-season agreement to appear on sleeve of FC Barcelona from 2026/2027 BARCELONA, Spain, Sept. 3, 2025 -- Midea and FC Barcelona are proud to announce that the world's No. 1 smart home appliance brand will join the La Liga and Copa del Rey champions as an FC Barcelona Main Partner from the 2026/2027 season. The historic 5-season agreement will see Midea appear on the sleeve of all of FC Barcelona's match jerseys and training wear as well as have extensive brand exposure during La Liga home matches. On Septem
- 황정호 기자
- 2025-09-03 01:38
US Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

SHANGHAI and JERSEY CITY, N.J., Sept. 2, 2025 -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) has approved BILDYOS® (denosumab-nxxp) injection 60 mg/mL and BILPREVDA® (denosumab-nxxp) injection 120 mg/1.7 mL, biosimilars to PROLIA (denosumab) and XGEVA (denosumab), respectively, for all indications of the reference products.1,2 "The FDA approvals of BILDYOS and BILPREVDA mark a significant step toward expanding access to critical bone care treatments needed by millions of people in the US, inclu
- 김갑성 기자
- 2025-09-02 21:10
NYSE Content Advisory: Pre-Market update + S&P 500 ends August up nearly 2%

NEW YORK, Sept. 2, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market update + S&P 500 ends August up nearly 2% Ashley Mastronardi delivers the pre-market update on September 2nd Stocks are mixed as investors enter September facing uncertainty. Over the weekend, a Federal Appeals Court ruled that most of President Trump's global tariffs are illegal, saying that only congres
- 황정호 기자
- 2025-09-02 21:01
Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants

- The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026- Selected researchers will receive up to USD 600,000 in research funding, along with access to Seegene's syndromic PCR assays, instruments, and software- Program aims to advance Seegene's Technology-Sharing Initiative and expand access to molecular diagnostics SEOUL, South Korea, Sept. 2, 2025 -- Seegene Inc., a global leader in molecular diagnostics, announced today the launch of the 20
- 김갑성 기자
- 2025-09-02 21:00
Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer's disease and Dementia Data

Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related data Enhancing dementia research by integrating AI imaging solutions with real-world data platforms SEOUL, South Korea, Sept. 2, 2025 -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it has signed a Memorandum of Understanding (MoU) with the International Registry for Alzheimer's Disease and Other Dementias Foundation (I
- 김갑성 기자
- 2025-09-02 21:00
Desilo to Launch "HARVEST™," Encrypted Data Collaboration Platform for Healthcare, in December

SEOUL, South Korea, Sept. 2, 2025 -- Desilo Inc., a privacy-technology startup specializing in cryptographic data collaboration, announced plans to launch its new healthcare platform, HARVEST™, this December. The platform is designed to allow medical institutions and pharmaceutical companies to collaborate on research without exposing sensitive patient data. Medical research often requires large, multi-institutional datasets, but privacy regulations and security risks have made data sharing difficult. According to IBM, the average cost of a healthcare data breach is $10.93 mill
- 김갑성 기자
- 2025-09-02 21:00
Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program

Milestone European deployment underscores growing global trust in Lunit's AI for population-wide breast cancer screening SEOUL, South Korea, Sept. 2, 2025 -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that its solutions have been selected as the exclusive AI tools for the breast cancer screening program of the Valencian Community, one of Spain's largest and most progressive healthcare regions. With a population of approximately 5 million, the Valencian Community is Spain's third-largest region by popul
- 김갑성 기자
- 2025-09-02 21:00
Nine Moments Witnessing Liaoning's Encounter with the World

OSAKA, Japan , Sept. 2, 2025 -- A report from China Trade News. From August 24 to 26, the Liaoning Week of the China Pavilion at the Expo 2025 Osaka presenting the world with a grand showcase of culture, technology, trade, and green development — A presentation on the Niuheliang Hongshan Culture Site, paired with artifacts displayed through cutting-edge naked-eye 3D holography, carried audiences on a journey across 5,000 years of history. "Liaoning Premium Products" and"China Fine Gifts", dazzled in glittering arrays. Tieling Errenzhuan, Jinzhou Shaobei martial arts
- 김장윤(JASON KIM) 기자
- 2025-09-02 20:41
BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform

XI'AN, China, Sept. 2, 2025 -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a groundbreaking identification of a class of natural polyphenolic compounds from a tea-derived product via its AI-Powered new drug research and development (R&D) platform. Preliminary tests demonstrate that these compounds exhibit significant activity in weight management, with key efficacy indicators outperforming current mainstream weight-managing drugs, injecting
- 황정호 기자
- 2025-09-02 20:30

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-09-03_WED

2025-09-02_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 03일 06시 40분